C-SUITE

The C-Suite is the exclusive domain of CEO’s both local and global with an emphasis on Company Results.

Peter Armitage CEO Anchor Capital weighs in exclusively on Naspers Prosus and Tencent in the C-SUITE

Peter Armitage, CEO of Anchor Capital, weighs in exclusively on Naspers Prosus and Tencent in the C-SUITE Naspers and Prosus make up more than 20% of the South African All Share Index. Within Naspers and Prosus 82% of the net asset value is in Tencent. Tencent is the biggest listed company in China and the company is currently around 40% off it's highs. On balance Anchor Capital is of the view that shareholders, risk profile dependent, should hold fast in the face...

South Africa in Crisis – Renowned Economist Mike Schussler is in the C-SUITE

South Africa in Crisis Renowned Economist Mike Schussler is in the C-SUITE We are at an inflection point in South Africa if the rioting and looting continues the long term economic consequences for the country are disastrous. Already growth is severely constrained and investor confidence has been extremely hard hit. We are in deep trouble. In this episode of the C-SUITE, we speak to renowned economist Mike Schussler. Watch all episodes of the C-SUITE. About Mike Schussler Winning the economist of the year award twice is...

EOH Boss Stephen Van Coller is in the C-SUITE

EOH Boss Stephen Van Coller is in the C-SUITE EOH's new management team delivers their first operating profit since they began their mammoth turnaround strategy of a group previously marred by legacy issues. The Group is now winning big multi year contracts. In this episode of the C-SUITE we chat with Stephen Van Coller. Watch all episodes of the C-SUITE here. About Stephen Van Coller Committed to disrupting traditional business to promote African continent growth through social inclusion Source: LinkedIn

Pieter Bensch EVP Sage Africa and Middle East is in the C-SUITE

Sage reported robust annual results Pieter Bensch EVP Sage Africa and Middle East is in the C-SUITE Sage services 3 million small businesses globally and despite COVID-19 reported a strong performance for the 12 months to the end of September 2020. The Group's results are testimony to just how import their payroll and accounting software packages are to small and medium enterprises. Watch all episodes of the C-SUITE here. About Pieter Bensch, Executive Vice President Sage Africa & Middle East As Executive Vice President for...

Agility CEO Geoffrey White is in the C Suite

Agility CEO Geoffrey White is in the C Suite Agility is one of the world's top integrated logistics companies and the largest private owner and developer of industrial real estate in the Middle East and North Africa. CEO Geoffrey White weighs in on the last 12 months and the impact of COVID-19 on the group saying its been a tough year but demand for warehousing is strong with ecommerce requiring hugely increased storage capacity. Watch all episodes of the C-SUITE.

Aspen Pharmacare CEO Stephen Saad is in the C-SUITE on the manufacture of COVID-19 vaccine in SA.

Aspen Pharmacare CEO Stephen Saad is in the C-SUITE on the manufacture of COVID-19 vaccine in SA. Johnson and Johnson have agreed to the supply of 250 million vaccines for Africa with 30 million being for South Africa. Aspen Pharmacare will be manufacturing these vaccines at Aspen's sterile facility in the Eastern Cape. Watch all episodes of the C-SUITE.

Afrimat CEO Andries Van Heerden is in the C- Suite

Afrimat CEO Andries Van Heerden is in the C- Suite Afrimat recently released its interim results. Its a company that continues to build value for shareholders through nimble acquisitions and subsequent integration of those businesses across three divisions: construction materials, industrial minerals and the commodities business. CEO Andries Van Heerden says the company is currently examining how to best position itself to get a bite out of the current shake up in the construction industry. Afrimat is debt free and in a...

Magda Wierzycka is in the C-SUITE

Magda Wierzycka is in the C-SUITE Wierzycka steps down as Co-CEO of Sygnia in a planned move to focus on providing strategic direction for the company from an innovation perspective. Wierzycka and her husband retain majority control of Sygnia and have no intention of reducing their stake as they see Sygnia's journey has just begun. Magda also provides an update on the hotly debated AstraZeneca Vaccine. Watch all episodes of the C-SUITE. About Magda Wierzycka Founder and Executive Chairman Magda is the force behind the...